These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11103926)

  • 81. The statistical approach in trial-based economic evaluations matters: get your statistics together!
    Mutubuki EN; El Alili M; Bosmans JE; Oosterhuis T; J Snoek F; Ostelo RWJG; van Tulder MW; van Dongen JM
    BMC Health Serv Res; 2021 May; 21(1):475. PubMed ID: 34011337
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods.
    Sadatsafavi M; Marra C; Aaron S; Bryan S
    Trials; 2014 Jun; 15():201. PubMed ID: 24888356
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bayesian variable selection in cost-effectiveness analysis.
    Negrín MA; Vázquez-Polo FJ; Martel M; Moreno E; Girón FJ
    Int J Environ Res Public Health; 2010 Apr; 7(4):1577-96. PubMed ID: 20617047
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.
    Skrepnek GH
    Pharmacoeconomics; 2007; 25(8):649-64. PubMed ID: 17640107
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.
    Hoch JS; Rockx MA; Krahn AD
    BMC Health Serv Res; 2006 Jun; 6():68. PubMed ID: 16756680
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Surgeons' economic profiles: can we get the "right" answers?
    Eisenstein EL; Bethea CF; Muhlbaier LH; Davidian M; Peterson ED; Stafford JA; Mark DB
    J Med Syst; 2005 Apr; 29(2):111-24. PubMed ID: 15931798
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Incorporation of genuine prior information in cost-effectiveness analysis of clinical trial data.
    Stevens JW; O'Hagan A
    Int J Technol Assess Health Care; 2002; 18(4):782-90. PubMed ID: 12602079
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Popping the cost balloon. Angioplasty study should be a harbinger, but budgets, entropy stall reform.
    Sloane T
    Mod Healthc; 2007 Apr; 37(15):21. PubMed ID: 17494354
    [No Abstract]   [Full Text] [Related]  

  • 89. Cost analysis between stent and conventional balloon angioplasty.
    Kobayashi Y; De Gregorio J; Yamamoto Y; Komiyama N; Miyazaki A; Masuda Y
    Jpn Circ J; 2000 Mar; 64(3):161-4. PubMed ID: 10732845
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty.
    Al MJ; Van Hout BA
    Health Econ; 2000 Oct; 9(7):599-609. PubMed ID: 11103926
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Direct coronary stenting compared with stenting after predilatation is feasible, safe, and more cost-effective in selected patients: evidence to date indicating similar late outcomes.
    Ijsselmuiden AJ; Tangelder GJ; Cotton JM; Vaijifdar B; Kiemeneij F; Slagboom T; v d Wieken R; Serruys PW; Laarman GJ
    Int J Cardiovasc Intervent; 2003; 5(3):143-50. PubMed ID: 12959731
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.